Apremilast as an Off-Label Therapeutic Agent: A Comprehensive Review of Safety and Efficacy Data in the Literature for Combination Therapy and Inflammatory Dermatoses. (2021). SKIN The Journal of Cutaneous Medicine, 5(3), 203-227. https://doi.org/10.25251/skin.5.3.2